The center will be able to screen for monkey fever, Nipah, and other uncommon illnesses with the addition of more modern facilities and associated upgrades.
ALAPPUZHA: The delay in upgrading the laboratory at the National Institute of Virology (NIV) in Alappuzha to biosafety level 3 (BSL-3) is hindering the early detection of disease outbreaks in the state, including Nipah.
The cutting-edge laboratory was launched in a new facility about a year ago. The Rs 25-crore structure is located in Kuravanthodu, near Punnapra, on
5.5 acres of property that was previously owned by the Alappuzha Medical College Hospital. NIV was given the plot in 2012.
The laboratory serves as a satellite of the NIV Pune. “The project was approved by the Union government in 2006.” However, the building did not begin until 2012. “Steps are being taken to upgrade it to BSL-3,” an official stated.
It is now permitted to test samples for coronavirus, chikungunya, and dengue. As COVID wreaked havoc in 2019, the Union Ministry of Health and the Indian Council of Medical Research (ICMR) allowed sophisticated testing to identify the new coronavirus (nCoV) and other viruses.
The center will be able to screen for monkey fever, Nipah, and other uncommon illnesses with the addition of more modern facilities and associated upgrades.
The NIV Alappuzha complex comprises guest accommodations and an animal house, identical to the one at NIV Pune, for performing controlled animal research.
“When the facility is fully operational, it will be able to conduct research on more than 40 diseases.” It would be capable of detecting illnesses such as Nipah, Japanese encephalitis, West Nile, dengue, kyasanur forest sickness (monkey fever), and H1N1, and the test findings will be validated by the federal government and the ICMR,” the official added.
Vinayagar Chaturthi: Plastic and thermocol not allowed for idol immersion in Tamil Nadu